The surgical management of patients with tetralogy of Fallot and significant right ventricular outflow tract obstruction (RVOTO) remains controversial. The authors describe the use of a monocusp in patients with right ventricular outflow tract obstruction.
Patient Selection
The surgical management of patients with tetralogy of Fallot and significant right ventricular outflow tract obstruction (RVOTO) remains controversial. For patients who have a congenitally small pulmonary valve annulus who are not candidates for a valve-sparing repair, there have historically been two options: (1) transannular patch or (2) valved conduit insertion. The advantage of the transannular patch is that it relieves the RV pressure immediately and the child usually will not require reoperation for RV outflow tract stenosis. A disadvantage of this technique is the sudden hemodynamic change for the RV from a pressure-loaded to a volume-loaded ventricle, which, when combined with VSD closure on one side and ventriculotomy on the other, often causes temporary RV dysfunction. The chronic volume overload can lead to ventricular dysfunction from chronic pulmonary valve insufficiency, and require late pulmonary valve insertion [1]. The advantage of the valved conduit technique is that it results in a reliable, fully competent pulmonary valve. This is particularly useful in patients who have peripheral unrepaired pulmonary stenosis. The disadvantage is that all conduits (or pulmonary valves) are subject to progressive stenosis, either from patient growth or calcification of the valves, and conduit replacement is eventually needed. An interesting alternative strategy is the creation of a monocusp RV outflow tract patch. A monocusp may be created with autologous or bovine pericardium [2], homograft pulmonary valve cusp, or as reported in this technique section, the use of PTFE pericardial membrane (0.1 mm PTFE patch) [3]. The monocusp has been shown, particularly in the immediate postoperative period, to prevent pulmonary valve insufficiency [4]. This may be associated with faster recovery of RV function, a lower central venous pressure, and less chest tube drainage. The construction of the monocusp is simple, very inexpensive, and reproducible. The potential disadvantage in comparison to insertion of a pulmonary valve or valved conduit is that, at least in some patients, there appears to be a faster progression to recurrent pulmonary valve insufficiency, although late stenosis is rarely, if ever, seen using this technique.
The patient selected for this procedure would be one for whom the surgeon would consider either a transannular patch or a pulmonary valve insertion at the time of initial tetralogy of Fallot repair, or a patient having a reoperation after initial transannular patch or valved conduit placement.
Operative Steps
Pulmonary Artery Incision

Ventriculotomy

PTFE Monocusp Creation

Monocusp Insertion

PTFE Outflow Tract Patch

Monocusp Function

Prior RVOT Conduit

Preference Card
Patch/Membrane
- 0.4 mm thickness cardiovascular patch (GORE-TEX® Cardiovascular Patch, W.L. Gore & Associates, Flagstaff, AZ)
- 0.1 mm thickness pericardial membrane (PRECLUDE® Pericardial Membrane, W.L. Gore & Associates, Flagstaff, AZ)
Sutures
- 6-0 PTFE suture (GORE-TEX® Suture, W.L. Gore & Associates, Flagstaff, AZ)
Equipment/Instruments
- Intraoperative transesophageal echocardiography
- Hegar or Amato dilators
Tips & Pitfalls
This operation lends itself well to following the carpenter’s rule: measure twice, cut once. If the PTFE monocusp patch is too small or too large, it may not work properly and would require reinstitution of cardiopulmonary bypass and revision of the patch. However, multiple suture lines in the RVOT will result in injury to the muscle in this area and make it difficult to obtain hemostasis. This also might place the patient at risk for development of a pseudoaneurysm through the suture line if there is sufficient damage to the edge of the muscle in this area. This technique is probably not suitable for patients who rely upon a competent pulmonary valve, i.e., patients with tetralogy of Fallot and absent pulmonary valve, or patients with significant peripheral pulmonary stenosis either congenital or secondary to previous aorto-pulmonary shunts. Patients with significant pulmonary hypertension might also be better served with the use of a valved conduit.
Results
At Indiana University, between June 1990 and June 1999, 158 patients underwent either PTFE monocusp RVOT reconstruction (n=115 patients, 120 implants) or non-valved transannular repair (n=43) [5]. Follow-up data are available at a mean of 2.6 years. There was no difference in postoperative mortality (2.6% versus 2.3%). There were no late deaths. Perioperative complications were not significantly different, nor were total hospital days. However, a significant difference in intensive care unit utilization (3.6 versus 5.8 days) favored monocusp patients. Patients with, specifically, tetralogy of Fallot or pulmonary atresia with ventricular septal defect undergoing monocusp implant demonstrated a trend towards improved survival when compared with transannular repairs. Intraoperative pulmonary insufficiency was graded mild in the monocusp group and moderate-to-severe in the transannular group. Progressive monocusp regurgitation occurred (mild to moderate) but remained significantly less than the transannular patch repairs.
Use of a PTFE monocusp valve prevents short-term and significantly reduces mid-term pulmonary valve insufficiency. It is inexpensive, easy to construct, and demonstrates no evidence of stenosis, calcification, or embolization. Despite slightly longer cardiopulmonary bypass times, it reduces intensive care unit stay and, in both tetralogy of Fallot and pulmonary atresia/VSD patients, its use decreases operative morbidity and mortality.
References
- Discigil B, Dearani JA, Puga FJ, et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001;121:344-51.
- Gundry, SR. Pericardial and synthetic monocusp valves: indication and results. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1999;2:77-82.
- Turrentine MW, McCarthy RP, Vijay P, et al. Polytetrafluoroethylene monocusp valve technique for right ventricular outflow tract reconstruction. Ann Thorac Surg 2002;74:2202-5.
- Gundry SR, Razzouk AJ, Boskind JF, et al: Fate of the pericardial monocusp pulmonary valve for right ventricular outflow tract reconstruction: Early function, late failure without obstruction. J Thorac Cardiovasc Surg 1994;107:908-13.
- Turrentine MW, McCarthy RP, Vijay P, et al. PTFE monocusp valve reconstruction of the right ventricular outflow tract. Ann Thorac Surg 2002;73:871-80.

